Spots Global Cancer Trial Database for Proton Radiotherapy for Recurrent Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Proton Radiotherapy for Recurrent Tumors
Official Title: Retreatment of Recurrent Tumors Using Proton Therapy
Study ID: NCT01126476
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to determine the feasibility of using proton radiotherapy for reirradiation of recurrent malignancies.
Detailed Description: Patients will be stratified by treatment site (Head and Neck, Thorax, Abdomen, Pelvis, Extremities) and by treatment volume (low volume, high volume) for a total of 10 strata. This study will be done in two phases. In the first phase, feasibility will be established using the primary objectives set below. The second phase will begin no earlier than 90 days after the last patient in the initial phase has completed treatment in each strata and once feasibility has been verified. The secondary objectives will serve as the objectives for the second phase of the study.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
ProCure Proton Therapy Center, Warrenville, Illinois, United States
Procure, Oklahoma City, Oklahoma, United States
Abamson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Contact Details
Name: John Plastaras, MD, PhD
Affiliation: Abramson Cancer Center at Penn Medicine
Role: PRINCIPAL_INVESTIGATOR
Name: Marcio Fagundes, MD
Affiliation: Procure, Oklahoma City, OK
Role: PRINCIPAL_INVESTIGATOR
Name: William F. Hartsell, MD
Affiliation: ProCure Proton Therapy Center, Warrenville, IL
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
